Healthcare

What’s Next for hVIVO in the FTSE AIM Sector Amidst Boardroom Change...

Highlights,hVIVO PLC (LSE:HVO), listed on the FTSE AIM All-Share Index, announces significant changes in its leadership structure.,Long-standing chair...

How Is Optima Health Shaping the FTSE AIM Health & Wellbeing Sector?

Highlights,Optima Health PLC has expanded its UK and Irish footprint through multiple acquisitions.,The company secured a long-term subcontract for UK...

What’s Driving Market Attention Toward This FTSE AIM 100 Healthcare...

Highlights,Belluscura PLC initiated a strategic review to explore business-enhancing options, leading to increased market scrutiny.,The company record...

How Is Oxford BioDynamics Advancing Genomic Diagnostics on the FTSE...

Highlights,Oxford BioDynamics receives ISO 15189 accreditation for its Oxford facility, strengthening its clinical testing infrastructure in the UK.,E...

Optima Health provides a combination of strong defensive features an...

Highlights,Optima Health PLC operates in the healthcare sector, offering outsourced occupational health services across the UK and Ireland,The company...

How is Kromek Group PLC Performing in the Technology Sector on FTSE...

Highlights,Kromek Group PLC (LSE: KMK) surpasses revenue and profit expectations for the fiscal year ending 30 April.,Advanced Imaging Division and si...

FTSE Now: Polarean Imaging's Progress and Market Trends

Highlights,Polarean Imaging's revenue surged significantly, reflecting strong market acceptance.,Strategic cost management has extended cash runway in...

How Is This FTSE Small Cap Imaging Firm Responding to US Market Pres...

Highlights,Polarean Imaging PLC (LSE: POLX), listed on the FTSE Small Cap index, maintains revenue projections despite funding constraints in the US a...

Could Optima’s Latest Move Propel ftse now Momentum Across Key Index...

Highlights,ftse now,focus sharpens as Optima Health PLC (ticker OPT) enters new service territory, reflecting trends in the FTSE AIM All-Share, FTSE 2...

Are UK Pharma and Tech Stocks Shaping FTSE 100 Index Movements?

Highlights,UK pharmaceutical stocks saw declines amid global regulatory developments,Defense and tech sectors showed contrasting performances within F...

Can Frontier IP’s ASF Vaccine Innovation Strengthen Biosecurity? | f...

Highlights,The Vaccine Group, a portfolio company of Frontier IP Group, begins animal testing for an ASF vaccine candidate.,The project is supported b...

Is Optima Health Strengthening Its FTSE 100 Live Position Through St...

Highlights,Optima Health PLC acquires Care first to expand its mental health services operations.,The move aligns with Optima’s long-term strategic gr...

How Is Itaconix Managing Tariff Impacts in the Detergent Polymers Ma...

Highlights,Itaconix reports strong detergent polymer demand early in the year amid changing global trade conditions.,Tariff changes have marginally af...

Can Genflow Biosciences Drive Innovation in the Biotech Sector Amid...

Highlights,Genflow Biosciences (GENF) received regulatory clearance to start direct clinical trials with MASH patients.,Research expanded into Werner...

Is Nuformix’s Inhaled Therapy Advancing Amid FTSE 350 Innovation Tre...

Highlights,Nuformix PLC posted widened losses and reduced cash reserves, while raising new funds through share subscriptions.,Discussions are ongoing...

What is the Latest Development from IQ-AI Ltd in Medical Imaging?

Highlights,IQ-AI Ltd (LSE:IQAI) is advancing in the medical imaging sector with a breakthrough therapy for glioblastoma.,The company’s subsidiary, Ima...

Is Totally PLC's Financial Stability in Question Amid Profit Revisio...

Highlights,Totally PLC reported a revised EBITDA outlook for the full year, citing lower margins and a phased contract completion.,The company's Chief...

Could GSK’s FTSE 100 and All-Share Status Gain from Nucala Trial Bre...

Could GSK’s FTSE 100 and All-Share Status Gain from Nucala Trial Breakthrough?

What’s Behind Genus’s Twenty-Seven Percent Surge in the FTSE 250?

What’s Behind Genus’s Twenty-Seven Percent Surge in the FTSE 250?

How Did GSK and Defensive Names Boost the FTSE 100 Amid US Data Shoc...

How Did GSK and Defensive Names Boost the FTSE 100 Amid US Data Shock?